Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 EUR | -0.98% | +2.02% | -42.61% |
01/07 | Nu Skin Enterprises, Inc.(NYSE:NUS) added to Russell 2000 Dynamic Index | CI |
09/05 | DA Davidson Adjusts Nu Skin Enterprises' Price Target to $12.50 From $15.50, Keeps Neutral Rating | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 12.08 for the current year.
- The company shows low valuation levels, with an enterprise value at 0.42 times its sales.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-42.61% | 55Cr | - | ||
+12.74% | 39TCr | C- | ||
+13.92% | 14TCr | B- | ||
+21.75% | 7.96TCr | A+ | ||
-4.36% | 7.17TCr | A- | ||
-27.28% | 3.81TCr | B+ | ||
-14.96% | 3.51TCr | - | ||
+0.41% | 3.3TCr | B- | ||
+9.36% | 1.83TCr | A- | ||
+21.45% | 1.68TCr | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NUS Stock
- NUS Stock
- Ratings Nu Skin Enterprises, Inc.